{"disease":{"id":"mgmt-unmethylated-glioblastoma","name":"mgmt unmethylated glioblastoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07452458","title":"Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":398,"lead_sponsor_name":"NRG Oncology","has_results":false},{"nct_id":"NCT04396860","title":"Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06504381","title":"DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05236036","title":"Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT05694416","title":"Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT05734560","title":"D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Darell Bigner","has_results":false},{"nct_id":"NCT04224441","title":"Repurposing Chlorpromazine in the Treatment of Glioblastoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":41,"lead_sponsor_name":"Marco G Paggi, MD, PhD","has_results":false},{"nct_id":"NCT05879250","title":"WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":39,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT05909618","title":"Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":33,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT03107780","title":"Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":32,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03250299","title":"Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":26,"lead_sponsor_name":"Basilea Pharmaceutica","has_results":true},{"nct_id":"NCT06186401","title":"Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Hideho Okada, MD, PhD","has_results":false},{"nct_id":"NCT03367715","title":"Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"NYU Langone Health","has_results":true},{"nct_id":"NCT03452930","title":"Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}